Burning Rock Biotech Limited American Depositary Receipt logo

Burning Rock Biotech Limited American Depositary Receipt (BNR)

Market Open
15 Jun, 14:30
NASDAQ (NMS) NASDAQ (NMS)
$
9. 01
+0.42
+4.8312%
$
9.13M Market Cap
- P/E Ratio
- Div Yield
2,661 Volume
0 Eps
$ 8.59
Previous Close
Investors:
Add Transaction
Day Range
8.54 9.38
Year Range
3.06 41.72
Want to track BNR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Burning Rock Biotech Limited American Depositary Receipt (BNR) Statistics

Valuation metrics

Market Cap 9.13M
Enterprise value -333.39M
Trailing P/E (ttm) -1.03
Forward P/E -28.79
PEG ratio -0.01
Price/Sales (ttm) 0.12
Price/Book (mrq) 0.12
Enterprise Value/Revenue -0.65
Enterprise Value/EBITDA 7.43

Overview

Shares outstanding 105.18M
Float 40.74M
Shares short 47.58K
% Held by insiders 0.04%
% Held by institutions 0.47%
Average volume (10 days) 37.26K
Average volume (90 days) 25.85K

Price summary

52-Week low 3.06
52-Week high 41.72
Beta 1.5
50-Day moving average 15.15
200-Day moving average 21.6

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 15 May 2024

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.12%
Operating margin -0.11%

Operational effectiveness

Return on assets -0.08%
Return on equity -0.11%

Income Statement

Revenue (ttm) 79.26M
Revenue per share (ttm) 489.02
Quarterly revenue growth (yoy) 0%
Gross profit (ttm) 59.19M
EBITDA -4.88M
Net income to common (ttm) -8.13M
Diluted EPS (ttm) -56.39
Quarterly earnings growth (yoy) 0%

Balance Sheet

Total cash (mrq) 70.63M
Total cash per share (mrq) 423.97
Total debt (mrq) 6.33M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.05%
Book value per share (mrq) 490.95

Cash Flow

Cash flow statement -4.18M
Levered free cash flow (LFCF) -3.35M